Stay updated on Dupilumab in Prurigo Nodularis: Clinical Trial

Sign up to get notified when there's something new on the Dupilumab in Prurigo Nodularis: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dupilumab in Prurigo Nodularis: Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page updates include a recruitment-status notice and new help/navigation sections, and a citation plus the 'Intervention/Treatment' header were removed.
    Difference
    0.3%
    Check dated 2026-06-15T18:11:50.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A new revision tag, v3.5.5, was added and the previous tag, v3.5.4, was removed, indicating a behind-the-scenes update to the page metadata.
    Difference
    0.0%
    Check dated 2026-06-08T14:47:53.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    An additional publication citation was added to the Publications section, and the page revision tag was updated to v3.5.4.
    Difference
    0.1%
    Check dated 2026-05-18T03:44:21.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page’s display footer was updated to show a new ClinicalTrials.gov site revision (v3.5.3 instead of v3.5.2). This reflects a back-end/site version update rather than any change to the study information.
    Difference
    0.0%
    Check dated 2026-04-26T08:22:00.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. This appears to be a minor version update with no visible changes to page content or functionality.
    Difference
    0.0%
    Check dated 2026-04-19T01:38:55.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    New publication citation added: Stander et al. Dupilumab Improves Prurigo Activity and Severity in Patients with Prurigo Nodularis: A Post Hoc Analysis of Pooled Results from the PRIME and PRIME2 Trials (Dermatol Ther, 2026).
    Difference
    0.0%
    Check dated 2026-04-04T19:22:34.000Z thumbnail image

Stay in the know with updates to Dupilumab in Prurigo Nodularis: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dupilumab in Prurigo Nodularis: Clinical Trial page.